What is the address of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE?

The registered office of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE is located at Rue du Thier-des-Gattes 25, 6950 Nassogne.

Is DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE still active?

Yes. According to the CBE (2 November 2026) DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE is active, legal situation “Normale toestand”, started on 21 January 2011.

Is DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE registered on Peppol?

No, DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE?

The enterprise number of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE is BE0833020459.

When was DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE founded?

DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE was founded on 21 January 2011.

Who are the directors of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE?

According to the 2024 annual accounts, the directors of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE are: Jean-Alain DECERF.

Is DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 January 2011; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE make in 2024?

DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE recorded a loss after taxes of € 1,834 in financial year 2024.

What is the revenue of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE?

As a small company, DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € -1,551.

DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE (Private Limited)

Dossier DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE, printed on 2 November 2026 from databakkes.be/en/0833020459/docteur-jean-alain-decerf-endocrinologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 0 % of short-term debt in 2024; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE from Nassogne, company number BE0833020459, closed financial year 2024 with a result of € -1,834 after tax. For that financial year DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE recorded a gross margin of € -1,551 and equity of € 788,294. Compared with financial year 2023, the result moved from € 24,201 to € -1,834. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2025.

What it is worth Healthy

€ 788,294

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1,834

▼ still € 24,201 profit in 2023

Profit after tax over the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 775,794.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 2,420

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 139,718 Gross margin 2021: € 139,718 First fiscal year in the series	€ -14,029 Gross margin 2022: € -14,029 ▼ € 153,747 vs 2021 (€ 139,718) Unfavourable step	€ 33,265 Gross margin 2023: € 33,265 ▲ € 47,294 vs 2022 (€ -14,029) Favourable step	€ -1,551 Gross margin 2024: € -1,551 ▼ € 34,816 vs 2023 (€ 33,265) Unfavourable step	▼ € 34,816
Profit after taxes	€ 47,470 Profit after taxes 2021: € 47,470 First fiscal year in the series	€ -27,677 Profit after taxes 2022: € -27,677 ▼ € 75,147 vs 2021 (€ 47,470) Unfavourable step	€ 24,201 Profit after taxes 2023: € 24,201 ▲ € 51,878 vs 2022 (€ -27,677) Favourable step	€ -1,834 Profit after taxes 2024: € -1,834 ▼ € 26,035 vs 2023 (€ 24,201) Unfavourable step	▼ € 26,035
Equity	€ 793,605 Equity 2021: € 793,605 First fiscal year in the series	€ 765,928 Equity 2022: € 765,928 ▼ 3% vs 2021 (€ 793,605) Unfavourable step	€ 790,128 Equity 2023: € 790,128 ▲ 3% vs 2022 (€ 765,928) Favourable step	€ 788,294 Equity 2024: € 788,294 Unchanged (€ 790,128) Unfavourable step
Total debts	€ 302,448 Total debts 2021: € 302,448 First fiscal year in the series	€ 318,545 Total debts 2022: € 318,545 ▲ 5% vs 2021 (€ 302,448) Unfavourable step	€ 210,033 Total debts 2023: € 210,033 ▼ 34% vs 2022 (€ 318,545) Favourable step	€ 211,706 Total debts 2024: € 211,706 ▲ 1% vs 2023 (€ 210,033) Unfavourable step	▲ 1%
Cash	€ 754 Cash 2021: € 754 First fiscal year in the series	-	€ 162 Cash 2023: € 162 First fiscal year in the series	-
Land & buildings	€ 94,573 Land & buildings 2021: € 94,573 First fiscal year in the series	€ 84,473 Land & buildings 2022: € 84,473 ▼ 11% vs 2021 (€ 94,573) Unchanged	-	-
Retained profit	€ 781,105 Retained profit 2021: € 781,105 First fiscal year in the series	€ 753,428 Retained profit 2022: € 753,428 ▼ 4% vs 2021 (€ 781,105) Unfavourable step	€ 777,628 Retained profit 2023: € 777,628 ▲ 3% vs 2022 (€ 753,428) Favourable step	€ 775,794 Retained profit 2024: € 775,794 Unchanged (€ 777,628) Unfavourable step
Bank debt	€ 72,961 Bank debt 2021: € 72,961 First fiscal year in the series	€ 53,987 Bank debt 2022: € 53,987 ▼ 26% vs 2021 (€ 72,961) Favourable step	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 53,987) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,096,053 Balance sheet total 2021: € 1,096,053 First fiscal year in the series	€ 1,084,473 Balance sheet total 2022: € 1,084,473 ▼ 1% vs 2021 (€ 1,096,053) Unchanged	€ 1,000,162 Balance sheet total 2023: € 1,000,162 ▼ 8% vs 2022 (€ 1,084,473) Unchanged	€ 1,000,000 Balance sheet total 2024: € 1,000,000 Unchanged (€ 1,000,162) Unchanged

Key figures of DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE?

What happened at DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 21, 2025 New annual accounts for financial year 2024: loss of € 1,834 (▼ € 26,035 vs 2023). filed late Source: NBB ↗
Mar 16, 2011 New establishment in Nassogne. KBO
Jan 21, 2011 Start of the company according to the CBE. KBO

In short

From € 47,470 profit in 2021 to € 1,834 loss in 2024.

Paid € 81,871 in corporate taxes since 2021.

Best year ever: 2021, with € 47,470 profit.

Original PDFs at the National Bank ↗

Management

Jean-Alain DECERF

DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE

Behind DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE is Jean-Alain DECERF.

Directors

According to the 2024 annual accounts

Jean-Alain DECERF

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Thier-des-Gattes 25

6950 Nassogne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0833.020.459
VAT number: BE 0833.020.459
Registered office: Rue du Thier-des-Gattes 25, 6950 Nassogne
Names & denominations: DOCTEUR JEAN-ALAIN DECERF - ENDOCRINOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 January 2011
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗